The activity of rosoxacin, fosfomycin, cefotiam, and spectinomycin on beta-lactamase producing Neisseria gonorrhoeae.
- 1 June 1984
- journal article
- research article
- Published by BMJ in Sexually Transmitted Infections
- Vol. 60 (3), 154-156
- https://doi.org/10.1136/sti.60.3.154
Abstract
The activity of rosoxacin, fosfomycin, cefotiam and spectinomycin was measured against 51 isolates of .beta.-lactamase producing N. gonorrhoeae, all of which were susceptible to each drug at sufficient concentrations. The development of strains of penicillinase producing N. gonorrhoeae (PPNG) which are resistant to spectinomycin can therefore be avoided, as there are alternative drugs.This publication has 10 references indexed in Scilit:
- In Vitro Susceptibility of 50 Non-β-Lactamase-Producing Neisseria gonorrhoeae Strains to 12 Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 1983
- Treatment of uncomplicated gonorrhoea in women. Comparison of rosoxacin and spectinomycin.Sexually Transmitted Infections, 1982
- Pharmacokinetics of Rosoxacin in Human VolunteersJournal of Pharmaceutical Sciences, 1982
- SPECTINOMYCIN-RESISTANT PENICILLINASE-PRODUCING NEISSERIA GONORRHOEAEThe Lancet, 1981
- [In vitro activity of rosoxacin (Win 35 213) against Neisseria gonorrhoeae (author's transl)].1980
- The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.1978
- Treatment of Acute and Subacute Gonococcal Urethritis with FosfomycinChemotherapy, 1977
- PENICILLINASE-PRODUCING GONOCOCCI IN LIVERPOOLThe Lancet, 1976